Cytokine involvement in dynorphin-induced allodynia
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Dynorphin A is an endogenous opioid peptide, which has previously been shown to produce a long-lasting allodynia and hyperalgesia in mice, behavioral states consistent with signs of clinically observed neuropathic pain. This dynorphin-induced allodynia was used as a pharmacological, central model of neuropathic pain. In this study, we examined the involvement of the cytokine IL-1beta, the transcription factor nuclear factor kappa B (NF-kappaB), and de novo protein synthesis in the development of allodynia induced by intrathecal (i.t.) administration of dynorphin in male ICR mice. Pretreatment with the protein synthesis inhibitor cycloheximide (0. 3-85nmol), the NF-kappaB inhibitor pyrrolidinedithiocarbamate (PDTC) (0.001-1000pmol), the IL-1 receptor antagonist (IL-1ra) protein (0. 01-100ng), the caspase-1 inhibitor (YVAD) (0.1-300pmol), and the anti-inflammatory cytokine IL-10 (0.1-300ng) all dose-dependently reduced the induction of dynorphin-induced allodynia. Finally, IL-10 administered within the first 24h after the dynorphin insult prevented the development of chronic allodynia. These results demonstrate that the anti-inflammatory cytokines IL-10 and IL-1ra impede the development of dynorphin-induced allodynia. These results also suggest that production of new proteins through NF-kappaB activation is required for the induction of allodynia. We speculate that IL-1ra, IL-10, PDTC and cycloheximide interfere with the central pro-inflammatory cascade. Modulation of cytokine activity in the spinal cord may therefore prove to be an effective therapeutic strategy for the treatment of chronic pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · cited 2×
“Several studies have shown the involvement of cytokines in the pathology of several neurological diseases, including Alzheimer's disease (Grif®n et al., 1989), AIDS dementia complex (Merrill and Chen, 1991), multiple sclerosis (Hofman et al.”
BackgroundDithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells.
Schreck, R., Meier, B., Männel, D. N., Dröge, W., & Baeuerle, P. A. (1992) · The Journal of experimental medicine · doi:10.1084/jem.175.5.1181 · Cited by 1,508
NF-kB: a crucial transcription factor for glial and neuronal cell function
O'Neill, L. A. J., & Kaltschmidt, C. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01035-1 · Cited by 1,013 · cited 3×
“…could perhaps up-regulate the expression of nociceptive agents such as pro-in¯ammatory cytokines, nitric oxide synthase, cyclooxygenase and dynorphin (O'Neill and Kaltschmidt, 1997), any of which might damage spinal neurons, generate nociceptive signals and activate NF-kB (Bethea et al., 1998).”
BackgroundInducible nitric oxide synthase gene expression in the brain during systemic inflammation
Wong, M.-L., Rettori, V., AL-Shekhlee, A., Bongiorno, P. B., Canteros, G., McCann, S. M., Gold, P. W., & Licinio, J. (1996) · Nature Medicine · doi:10.1038/nm0596-581 · Cited by 286 · cited 1×
“…factor-alpha (TNF-a ), are normally expressed in low concentrations in the brain; however, this expression increases after brain injury (Giulian and Lachman, 1985; Yan et al., 1992), ischemia (Buttini et al., 1994; Bhat et al., 1996), and in¯ammation (Wong et al., 1996; Woolf et al., 1997).”
Background
Cited by
Glial activation: a driving force for pathological pain
Watkins, L. R., Milligan, E. D., & Maier, S. F. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01854-3 · Cited by 1,088
GLIA: A novel drug discovery target for clinical pain
Watkins, L. R., & Maier, S. F. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1251 · Cited by 672
The role of neuroinflammation and neuroimmune activation in persistent pain
DeLeo, J. A., & Yezierski, R. P. (2001) · Pain · doi:10.1016/s0304-3959(00)00490-5 · Cited by 639
Self-citationHypernociceptive role of cytokines and chemokines: Targets for analgesic drug development?
Verri, W. A., Cunha, T. M., Parada, C. A., Poole, S., Cunha, F. Q., & Ferreira, S. H. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.001 · Cited by 542
Raghavendra, V., Rutkowski, M. D., & DeLeo, J. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09980.2002 · Cited by 469
Metadata
- Authors
- Laughlin, T. M., Bethea, J. R., Yezierski, R. P., & Wilcox, G. L.
- Venue
- Pain
- Published
- 2000-02-01
- Volume
- 84
- Issue
- 2
- Pages
- 159-167
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2042324518
- Cited by
- 154
- References
- 6
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cytokine involvement in dynorphin-induced allodynia. https://app.cochat.ai/papers/10.1016/s0304-3959(99)00195-5
- The paper
- Laughlin, T. M., Bethea, J. R., Yezierski, R. P., & Wilcox, G. L. (2000). Cytokine involvement in dynorphin-induced allodynia. Pain. https://doi.org/10.1016/s0304-3959(99)00195-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.